Sunday, February 07, 2010
There was some favorable data dredged out of these failed trials: A secondary analysis of pooled data documented increased time in the target range (60% vs 40%) and reduced time for which glucose concentrations were 3·90 mmol/L or lower (2·1% vs 4·1%). No events with plasma glucose concentration lower than 3·0 mmol/L were recorded during closed-loop delivery, compared with nine events during standard treatment. But if a study fails its primary endpoints, it's not a landmark study: it's a failed study.
The dream continues.
